Quantcast

Latest Heavy metal Stories

2014-06-17 08:28:25

CARLSBAD, Calif., June 17, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today it has earned a $10 million milestone payment from Biogen Idec associated with the validation of an undisclosed target to treat a neurological disorder. This is the first milestone payment under Isis' and Biogen Idec's 2013 strategic collaboration to advance the treatment of neurological disorders. This collaboration combines Biogen Idec's expertise in neurology with Isis'...

2014-06-12 08:28:34

CARLSBAD, Calif., June 12, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS), the leader in antisense therapeutics, today announced that management will present a company overview at the 2014 Wells Fargo Healthcare Conference at 1:10 p.m. ET and participate in the Gene Manipulation Panel at 2:20 p.m. ET on Tuesday, June 17, 2014 in Boston, MA. http://photos.prnewswire.com/prnvar/20130807/LA60006LOGO A live webcast of the presentations will be available on the "Investors...

2014-06-11 08:28:25

Event and webcast scheduled on Monday, June 16 at 6:30 a.m. Pacific Time CARLSBAD, Calif., June 11, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today that it will host an investor event and a live webcast on Monday, June 16, 2014 at 6:30 a.m. Pacific Time to discuss the ISIS-GCGR(Rx) Phase 2 data presented at the American Diabetes Association's 74(th) Scientific Sessions in San Francisco, CA. http://photos.prnewswire.com/prnvar/20130807/LA60006LOGO...

2014-06-03 08:31:23

CARLSBAD, Calif., June 3, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS), the leader in antisense therapeutics, today announced that management will present a general corporate update in conjunction with its 2014 Annual Meeting of Stockholders and Open House on Tuesday, June 10 at 2:10 p.m. Pacific Time in Carlsbad, CA. http://photos.prnewswire.com/prnvar/20130807/LA60006LOGO The agenda for the meeting is as follows:2:00 p.m. - 2:10 p.m. Annual Meeting of...

2014-05-28 23:18:55

Grammy award winning heavy metal guitarist, Mark Tremonti debuts his commissioned original Joe Fenton masterpiece PRS guitar by playing the guitar on stage to a sold out crowd at the Rock on the Range festival. Stevensville, MD (PRWEB) May 28, 2014 As an internationally recognized artist whose intricate drawings can be found in art galleries, corporate and private collections, Joe Fenton is represented internationally by Gallery House. Fenton works in monochrome using graphite, ink and...

2014-05-20 08:31:54

CARLSBAD, Calif., May 20, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today that it initiated a Phase 1 clinical study of ISIS-PKK(Rx). ISIS-PKK(Rx) is an antisense drug in development to treat patients with hereditary angioedemia (HAE). HAE is a rare genetic disease that is characterized by rapid and painful attacks of inflammation in the hands, feet, limbs, face, abdomen, larynx and trachea. HAE affects approximately 20,000 patients in the United...

2014-05-16 08:25:56

CARLSBAD, Calif., May 16, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announces the following webcast: What: Isis Pharmaceuticals' R&D Day Presentation When: Thursday, May 22 at 12:00 p.m. ET /9:00 a.m. PT Where: www.isispharm.com How: Live on the Internet. Simply log onto our website listed above. If you are unable to...

2014-05-15 08:31:23

CARLSBAD, Calif., May 15, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today that it has earned a $3.0 million milestone payment from GlaxoSmithKline (GSK) related to the initiation of a natural history study, which will support the advancement of one of the alliance programs. http://photos.prnewswire.com/prnvar/20130807/LA60006LOGO "We have had a very productive alliance with GlaxoSmithKline, from which we have advanced three antisense drugs in our...

2014-05-13 16:29:02

CARLSBAD, Calif., May 13, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS), the leader in antisense therapeutics, today announced that management will present a company overview at the UBS Global Healthcare Conference on Wednesday, May 21, 2014 at 8:00 a.m. ET in New York, NY. http://photos.prnewswire.com/prnvar/20130807/LA60006LOGO A live webcast of the presentation will be available on the "Investors & Media" section of the Company's website, www.isispharm.com....

2014-05-13 16:23:03

Metals Naturally Occurring Constituents in Healthy Soils LOS ANGELES, May 13, 2014 /PRNewswire/ -- Axiom Foods, whose Oryzatein(®) enzyme-extracted, brown rice protein is supplied to food and beverage manufacturers throughout the U.S., Europe and other countries, is embarking on a campaign to educate consumers about the reality of heavy metals in plant food--As Dr. Oz said in a recent segment, the people have the right to know the truth. It is important to know that those whose diets consist...


Latest Heavy metal Reference Libraries

Brilliant Emerald, Somatochlora metallica
2013-07-30 14:54:37

The brilliant emerald (Somatochlora metallica) is a species of dragonfly that can be found in northern areas of Eurasia. Its range includes Austria, Belgium, Croatia, Denmark, France, Germany, Norway, Serbia, Sweden, and the United Kingdom, among many other areas. This species prefers to reside near still and slow-moving water sources like rivers, canals, ponds, and moorland lakes. It is common in most areas of its range, but its total population number and population trend is unknown. It is...

More Articles (1 articles) »
Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.